Get started
CARDINAL HEALTH INC CEDEAR EACH 3 REP 1 NPV (USD)CC

CARDINAL HEALTH INC CEDEAR EACH 3 REP 1 NPV (USD)

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

CAHD trade ideas

Cardinal Health, Inc. (CAH) | Chart & Forecast SummaryKey Indicators on Trade Set Up in General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Active Sessions on Relevant Range & Elemented Probabilities; * Asian(Ranging) - London(Upwards) - NYC(Downwards) * Weekend Crypto Session # Trend | Time Frame Conductive | Weekly Time Frame - General Trend - Measurement on Session * Support & Resistance * Trade Area | Focus & Motion Ahead # Position & Risk Reward | Daily Time Frame - Measurement on Session * Retracement | 0.5 & 0.618 * Extension | 0.786 & 1 Conclusion | Trade Plan Execution & Risk Management on Demand; Overall Consensus | Buy
CAPITALCOM:CAHLong
by TradePolitics
$CAH Wholesale Opportunity #BuyWholesaleSellRetail This is a wholesale opportunity with Cardinal Health NYSE:CAH . Profit margin looks good. Stock is in an upward trend with higher highs and higher lows. Cardinal Health trades at a reasonable P/E ratio compared to peers in pharmaceutical wholesale sector. Moving averages indicate a bullish trend. Cardinal Health offers a wholesale opportunity with its strong market position, solid financial health, and positive stock performance.
NLong
by ImmaculateTony
Recommend adding Cardinal Health to your watch list - $64 TargetThis is more of investment logic than trading logic. I was keeping an eye on Cardinal to see if this Inverted H&D would play out, and it did not. Will be watching to see where it finds support - I am expecting it will be off the 20dma. If we see a nice morning star, or bullish hammer I will be looking to build a long from that point. I am keeping an eye on the weekly TF, not the daily as the reason I want to be in CAH is for the cheap value and 3.55% Dividend. Market Cap 15.96B Income -4158M Sales 153.59B Book/sh 4.12 Forward P/E 9.90 (Very inexpensive) P/FCF 12.46 (Bullish) Debt/Eq 6.04 EPS this Y +308% Sales Q/Q +11.2% EPS Q/Q +20.3% Earnings Aug 6th Gross Margin +4.5% ROE -176.4% (Very bearish) Profit MArgin -2.7% Short Float 1.75% Long term Target will be $64
N
by ZenMode
2
CAH BullishThe flag pattern and engulfing candle are both very bullish signals. In addition the MACD histogram is rising, suggesting momentum is increasing and a MACD crossover is imminent. OBV confirms the recent price action. Both the short term FI (2) and long term FI (13) are recently positive showing a good entry point and confirmation of the trend. Finally, the most recent candles tested multiple Fibonacci levels managing to close above the .78 level. Target: $79, $91
NLong
by Master_of_Fine_Charts
Politics & Healthcare say what you will about politics, there's some interesting correlations between healthcare stocks and what U.S. President party presides. Cardinal Health ripped during the Obama years, looks like a rally underway with Biden in the oval office. When nothing else works, healthcare does. I think companies like this are poised for a comeback. Long shares & calls at these levels. We bounced off what I call "Bush Jr." support and there's a huge gap up to fill. Bullish outlook is this thing could nearly double in the next couple years, but near term PT $75.75 where things took a big dump after Trump entered office. Disclaimer: I'm not political so take your rhetoric and hash it out with people who care. I'm simply here to look at data & make money. 🤙🏽
NLong
by QUANDRANTS
Cardinal Health working on breaking through resistanceCardinal health is currently sitting at a resistance level that held from 2000-2013. From 2014-2018 it traded above this resistance level, but in 2018 it dropped back below it. For the last two years, the stock has been trying to break through this level, but has been rejected roughly 19 times. Thanks to trend line support, we're coming toward a decision point within the next few months. I think there are several good reasons to think we could see a successful breakout soon. Valuation I estimate CAH's forward P/E below 9, and its forward P/S at an amazing 0.09. The stock should have a forward dividend yield of about 3.5%. It's not much of an innovator, but its pace of patent filing has been picking up over the last few years. CAH has been growing earnings at an annual rate of about 1.5%, sales at a rate of over 2%, the dividend at 0.5%, and free cash flow at a rate 4%. So it's a growing company with lots of free cash flow and a very attractive PEG ratio. I estimate that CAH has about 17% upside to its median price multiple of the last 4 years, so the stock looks undervalued here. Sentiment S&P Global Market Intelligence gives CAH an average rating of 86.75/100. It gets a better-than-average ESG score as well. The average analyst score, according to Thompson-Reuters Starmine, is 9/10. This score has recently increased by several points. Open interest from option traders is in bullish territory, at 0.9. Technicals are bullish, and CAH has 17.5% upside to the average analyst price target. Overall, sentiment looks quite positive for CAH.
NLong
by ChristopherCarrollSmith
3